Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mentors | 2 | 2024 | 145 | 1.400 |
Why?
|
| Students | 6 | 2025 | 626 | 1.000 |
Why?
|
| Biomedical Research | 4 | 2024 | 502 | 0.870 |
Why?
|
| Faculty | 2 | 2024 | 105 | 0.840 |
Why?
|
| Housing | 1 | 2022 | 74 | 0.710 |
Why?
|
| Electric Stimulation Therapy | 3 | 2025 | 18 | 0.650 |
Why?
|
| Research Design | 1 | 2021 | 385 | 0.590 |
Why?
|
| Universities | 5 | 2025 | 559 | 0.410 |
Why?
|
| Hyperglycemia | 2 | 2025 | 61 | 0.390 |
Why?
|
| Likelihood Functions | 1 | 2011 | 62 | 0.340 |
Why?
|
| Linear Models | 1 | 2011 | 317 | 0.320 |
Why?
|
| Logistic Models | 1 | 2011 | 1009 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1124 | 0.270 |
Why?
|
| Humans | 17 | 2025 | 43102 | 0.230 |
Why?
|
| Carbohydrate Metabolism | 1 | 2025 | 26 | 0.230 |
Why?
|
| Resistance Training | 1 | 2025 | 21 | 0.220 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 9 | 0.220 |
Why?
|
| Muscle Strength | 1 | 2025 | 37 | 0.220 |
Why?
|
| Chemokine CCL19 | 1 | 2024 | 10 | 0.220 |
Why?
|
| Receptors, CCR7 | 1 | 2024 | 19 | 0.220 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2023 | 6 | 0.200 |
Why?
|
| Research Personnel | 1 | 2024 | 206 | 0.200 |
Why?
|
| Research | 1 | 2024 | 181 | 0.190 |
Why?
|
| Overweight | 1 | 2025 | 249 | 0.190 |
Why?
|
| Amyloidosis | 1 | 2022 | 37 | 0.190 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 61 | 0.180 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 316 | 0.180 |
Why?
|
| Environment | 2 | 2020 | 149 | 0.180 |
Why?
|
| Sexual Behavior, Animal | 1 | 2021 | 64 | 0.170 |
Why?
|
| Postoperative Complications | 1 | 2023 | 263 | 0.170 |
Why?
|
| Food Supply | 1 | 2022 | 122 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 1 | 2021 | 125 | 0.170 |
Why?
|
| Crisis Intervention | 1 | 2020 | 9 | 0.170 |
Why?
|
| Government Programs | 1 | 2020 | 29 | 0.160 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 218 | 0.160 |
Why?
|
| Social Behavior | 1 | 2021 | 161 | 0.160 |
Why?
|
| Male | 10 | 2025 | 23409 | 0.160 |
Why?
|
| Animal Migration | 1 | 2019 | 6 | 0.160 |
Why?
|
| Viperidae | 1 | 2019 | 3 | 0.160 |
Why?
|
| Mating Preference, Animal | 1 | 2019 | 7 | 0.160 |
Why?
|
| Science | 1 | 2020 | 24 | 0.160 |
Why?
|
| Obesity | 2 | 2025 | 1151 | 0.160 |
Why?
|
| Seasons | 1 | 2019 | 139 | 0.150 |
Why?
|
| Reproduction | 1 | 2019 | 94 | 0.150 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 193 | 0.150 |
Why?
|
| Cultural Diversity | 1 | 2020 | 193 | 0.150 |
Why?
|
| Female | 9 | 2025 | 24698 | 0.140 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 149 | 0.140 |
Why?
|
| Quality of Life | 1 | 2023 | 616 | 0.140 |
Why?
|
| Ecosystem | 1 | 2019 | 175 | 0.140 |
Why?
|
| Lead | 1 | 2019 | 100 | 0.140 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 1234 | 0.140 |
Why?
|
| Synapses | 1 | 2019 | 185 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1081 | 0.130 |
Why?
|
| Alcoholism | 1 | 2020 | 305 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2019 | 256 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 539 | 0.120 |
Why?
|
| Motivation | 1 | 2020 | 513 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 760 | 0.110 |
Why?
|
| Electric Stimulation | 2 | 2025 | 186 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3156 | 0.100 |
Why?
|
| Neurons | 1 | 2019 | 1263 | 0.090 |
Why?
|
| Blood Glucose | 2 | 2025 | 389 | 0.090 |
Why?
|
| Adult | 5 | 2025 | 13872 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2011 | 408 | 0.070 |
Why?
|
| Middle Aged | 4 | 2025 | 12222 | 0.070 |
Why?
|
| Young Adult | 3 | 2025 | 5080 | 0.070 |
Why?
|
| Animals | 5 | 2024 | 16992 | 0.070 |
Why?
|
| Quadriceps Muscle | 1 | 2025 | 8 | 0.060 |
Why?
|
| Chemokine CCL21 | 1 | 2024 | 14 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2024 | 68 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2025 | 187 | 0.050 |
Why?
|
| Brain | 2 | 2022 | 1472 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2024 | 152 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2024 | 290 | 0.050 |
Why?
|
| Health Services | 1 | 2023 | 61 | 0.050 |
Why?
|
| Texas | 1 | 2024 | 457 | 0.050 |
Why?
|
| Rodentia | 1 | 2022 | 47 | 0.050 |
Why?
|
| Amyloid | 1 | 2022 | 65 | 0.050 |
Why?
|
| Arvicolinae | 1 | 2021 | 20 | 0.050 |
Why?
|
| United States | 2 | 2025 | 5205 | 0.040 |
Why?
|
| Adolescent | 2 | 2025 | 6081 | 0.040 |
Why?
|
| Mice | 2 | 2024 | 6644 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 655 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 1067 | 0.040 |
Why?
|
| Aged | 2 | 2023 | 8214 | 0.040 |
Why?
|
| Laboratories | 1 | 2020 | 40 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 120 | 0.040 |
Why?
|
| Time | 1 | 2019 | 15 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 861 | 0.040 |
Why?
|
| Income | 1 | 2020 | 160 | 0.040 |
Why?
|
| Geography | 1 | 2019 | 110 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1063 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 59 | 0.040 |
Why?
|
| Educational Status | 1 | 2020 | 339 | 0.040 |
Why?
|
| Learning | 1 | 2020 | 161 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2676 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 2853 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1600 | 0.030 |
Why?
|
| Age Factors | 1 | 2019 | 1154 | 0.030 |
Why?
|
| Hippocampus | 1 | 2019 | 594 | 0.030 |
Why?
|